Fig. 8
A) Flowcytometric analysis data showing average percentages of early and late apoptotic cells in DTXtreated cells, cat, and v/v combination of DTX + cat. All treatments mostly induced apoptosis particularly the combination treatment; *: Significant vs. un-treated control cells at P < 0.01; a: Significant vs. G2 and G3 at P < 0.001. B-E) Instance flow cytometry dot plot log graphs indicating the percent of early and late apoptotic cells in treated and untreated PC3 prostate carcinoma cells; B) PC3 un-treated cells, C) Cat treatment, D) DTX treatment, E: Combination treatment. Inside each dot plot log figure, the upper left square is % of necrotic dead cells; lower left: % of viable cells; upper right; % of late apoptotic cells; lower right: % of early apoptotic cells.

A) Flowcytometric analysis data showing average percentages of early and late apoptotic cells in DTXtreated cells, cat, and v/v combination of DTX + cat. All treatments mostly induced apoptosis particularly the combination treatment; *: Significant vs. un-treated control cells at P < 0.01; a: Significant vs. G2 and G3 at P < 0.001. B-E) Instance flow cytometry dot plot log graphs indicating the percent of early and late apoptotic cells in treated and untreated PC3 prostate carcinoma cells; B) PC3 un-treated cells, C) Cat treatment, D) DTX treatment, E: Combination treatment. Inside each dot plot log figure, the upper left square is % of necrotic dead cells; lower left: % of viable cells; upper right; % of late apoptotic cells; lower right: % of early apoptotic cells.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close